Literature DB >> 26004349

Synthesis of mannoheptose derivatives and their evaluation as inhibitors of the lectin LecB from the opportunistic pathogen Pseudomonas aeruginosa.

Anna Hofmann1, Roman Sommer2, Dirk Hauck2, Julia Stifel1, Inigo Göttker-Schnetmann1, Alexander Titz3.   

Abstract

Biofilm formation and chronic infections with Pseudomonas aeruginosa depend on lectins produced by the bacterium. The bacterial C-type lectin LecB binds to the two monosaccharides l-fucose and d-mannose and conjugates thereof. Previously, d-mannose derivatives with amide and sulfonamide substituents at C6 were reported as potent inhibitors of the bacterial lectin LecB and LecB-mediated bacterial surface adhesion. Because d-mannose establishes a hydrogen bond via its 6-OH group with Ser23 of LecB in the crystal structure and may be beneficial for binding affinity, we extended d-mannose and synthesized mannoheptoses bearing the free 6-OH group as well as amido and sulfonamido-substituents at C7. Two series of diastereomeric mannoheptoses were synthesized and the stereochemistry was determined by X-ray crystallography. The potency of the mannoheptoses as LecB inhibitors was assessed in a competitive binding assay. The data reveal a diastereoselectivity of LecB for (6S)-mannoheptose derivatives with increased activity over methyl α-d-mannoside.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Inhibitor; Lectin; Pseudomonas aeruginosa

Mesh:

Substances:

Year:  2015        PMID: 26004349     DOI: 10.1016/j.carres.2015.04.010

Source DB:  PubMed          Journal:  Carbohydr Res        ISSN: 0008-6215            Impact factor:   2.104


  6 in total

1.  Cinnamide Derivatives of d-Mannose as Inhibitors of the Bacterial Virulence Factor LecB from Pseudomonas aeruginosa.

Authors:  Roman Sommer; Dirk Hauck; Annabelle Varrot; Stefanie Wagner; Aymeric Audfray; Andreas Prestel; Heiko M Möller; Anne Imberty; Alexander Titz
Journal:  ChemistryOpen       Date:  2015-10-13       Impact factor: 2.911

2.  The virulence factor LecB varies in clinical isolates: consequences for ligand binding and drug discovery.

Authors:  Roman Sommer; Stefanie Wagner; Annabelle Varrot; Corwin M Nycholat; Ariane Khaledi; Susanne Häussler; James C Paulson; Anne Imberty; Alexander Titz
Journal:  Chem Sci       Date:  2016-05-11       Impact factor: 9.825

3.  Anti-biofilm Agents against Pseudomonas aeruginosa: A Structure-Activity Relationship Study of C-Glycosidic LecB Inhibitors.

Authors:  Roman Sommer; Katharina Rox; Stefanie Wagner; Dirk Hauck; Sarah S Henrikus; Shelby Newsad; Tatjana Arnold; Thomas Ryckmans; Mark Brönstrup; Anne Imberty; Annabelle Varrot; Rolf W Hartmann; Alexander Titz
Journal:  J Med Chem       Date:  2019-10-11       Impact factor: 7.446

Review 4.  Structural Considerations for Building Synthetic Glycoconjugates as Inhibitors for Pseudomonas aeruginosa Lectins.

Authors:  Karolina Wojtczak; Joseph P Byrne
Journal:  ChemMedChem       Date:  2022-05-03       Impact factor: 3.540

5.  Targeting the Central Pocket of the Pseudomonas aeruginosa Lectin LecA.

Authors:  Eike Siebs; Elena Shanina; Sakonwan Kuhaudomlarp; Priscila da Silva Figueiredo Celestino Gomes; Cloé Fortin; Peter H Seeberger; Didier Rognan; Christoph Rademacher; Anne Imberty; Alexander Titz
Journal:  Chembiochem       Date:  2021-12-02       Impact factor: 3.461

6.  Covalent Lectin Inhibition and Application in Bacterial Biofilm Imaging.

Authors:  Stefanie Wagner; Dirk Hauck; Michael Hoffmann; Roman Sommer; Ines Joachim; Rolf Müller; Anne Imberty; Annabelle Varrot; Alexander Titz
Journal:  Angew Chem Int Ed Engl       Date:  2017-11-28       Impact factor: 15.336

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.